CO5160305A1 - Derivados de 2-alcoxi-ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de 2-alcoxi-ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica

Info

Publication number
CO5160305A1
CO5160305A1 CO00028248A CO00028248A CO5160305A1 CO 5160305 A1 CO5160305 A1 CO 5160305A1 CO 00028248 A CO00028248 A CO 00028248A CO 00028248 A CO00028248 A CO 00028248A CO 5160305 A1 CO5160305 A1 CO 5160305A1
Authority
CO
Colombia
Prior art keywords
carbon atoms
ciclobuten
alcoxi
diona
therapeutics
Prior art date
Application number
CO00028248A
Other languages
English (en)
Inventor
Philippe R Bovy
Claudie Gautier
Christophe Philippo
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5160305A1 publication Critical patent/CO5160305A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos de fórmula general (I):<EMI FILE="00028248_1" ID="1" IMF=JPEG >en la cual:R1 y R2 representan, independientemente entre sí, un átomo de hidrógeno o un grupo alquilo de 1 a 3 átomos de carbono,R3 representa un átomo de hidrógeno o un grupo alquilo de 1 a 6 átomos de carbono, W representa un grupo OR4, yR4 representa un grupo alquilo de 1 a 10 átomos de carbono, alquenilo de 2 a 6 átomos de carbono, alquinilo de 2 a 6 átomos de carbono, C3-6 cicloalquilo-C1-3alquilo-, bencilo, o fluoroalquilo de 1 a 6 átomos de carbono.
CO00028248A 1999-04-20 2000-04-17 Derivados de 2-alcoxi-ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica CO5160305A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904945A FR2792634B1 (fr) 1999-04-20 1999-04-20 Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
CO5160305A1 true CO5160305A1 (es) 2002-05-30

Family

ID=9544620

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00028248A CO5160305A1 (es) 1999-04-20 2000-04-17 Derivados de 2-alcoxi-ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica

Country Status (6)

Country Link
AR (1) AR023548A1 (es)
AU (1) AU3971800A (es)
CO (1) CO5160305A1 (es)
FR (1) FR2792634B1 (es)
UY (1) UY26110A1 (es)
WO (1) WO2000063160A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495576B2 (en) 2001-02-07 2002-12-17 Abbott Laboratories Aminal diones as potassium channel openers
DE10135815A1 (de) * 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
US20050107394A1 (en) * 2001-12-17 2005-05-19 Ardeschir Ghofrani Novel use of selective pde5 inhibitors
FR2842271B1 (fr) 2002-07-15 2004-09-10 Eurocopter France Boite de transmissiion de puissance basculante a transfert de charge par le carter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311282D0 (en) * 1993-06-01 1993-07-21 Rhone Poulenc Rorer Ltd New compositions of matter

Also Published As

Publication number Publication date
FR2792634B1 (fr) 2001-06-01
WO2000063160A1 (fr) 2000-10-26
FR2792634A1 (fr) 2000-10-27
AR023548A1 (es) 2002-09-04
UY26110A1 (es) 2000-12-29
AU3971800A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
CO5180557A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas y sus composiciones farmaceuticas .
ES8206488A1 (es) Un procedimiento para preparar compuestos de purina y piri- midina
IL154272A (en) Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
RU96119782A (ru) Производные 7-амино-1h-индола
HUP0000343A2 (hu) 1,3-Propándiol-származékok alkalmazása szervátültetés után fellépő kilökődés megakadályozására
DE69208955D1 (de) Pyrimidin-4-carboxamidderivate, ihre Herstellung und ihre Verwendung in der Therapie
RS50229B (sr) Analozi vitamina d3
EP1189900A4 (en) HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES FOR USE AS MELATONERGIC AGENTS
TW427979B (en) A condensed piperidine compound
ES2045485T3 (es) Metodo de preparacion de derivados de fenil-6 piperazinilalquil-3 1h, 3h-pirimidinediona-2,4, y su aplicacion en terapeutica.
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
BR0108046A (pt) Compostos azol condensados e seu uso como agentes hipoglicêmicos
KR860700250A (ko) 신규 아미딘 화합물
CO5160305A1 (es) Derivados de 2-alcoxi-ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica
CO5200762A1 (es) Preparacion de piperidin-4-onas sustituidas
DK1569993T3 (da) Bitumenpræparat
KR850001213A (ko) 이미다조[1,5-a] 피리미딘 유도체의 제조방법
KR900016178A (ko) 2-치환 n,n&#39;-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
CO5210926A1 (es) Mezclas fungicidas
RU2219161C2 (ru) Способ синтеза таксанов
AR019701A1 (es) Compuestos derivados de alfa-d-xilosa, preparacion y su utilizacion en terapeutica
CA2228078A1 (en) Composition for oral administration containing pyridazinone compounds
CO5140085A1 (es) Derivados terapeuticos de benzamida
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
CO5160254A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica